Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3271307)

Published in Curr Genomics on December 01, 2011

Authors

Oliver J Brand1, Stephen C L Gough

Author Affiliations

1: Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Oxford, UK.

Articles cited by this

(truncated to the top 100)

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95

A map of human genome variation from population-scale sequencing. Nature (2010) 121.13

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20

A fine-scale map of recombination rates and hotspots across the human genome. Science (2005) 26.82

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet (2007) 19.04

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90

Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered (2003) 14.37

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet (2004) 13.71

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00

CTLA-4 control over Foxp3+ regulatory T cell function. Science (2008) 12.67

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet (2004) 12.25

Evaluating coverage of genome-wide association studies. Nat Genet (2006) 11.40

Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27

The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53

A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet (2006) 8.65

Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature (1985) 7.77

Genome structural variation discovery and genotyping. Nat Rev Genet (2011) 7.34

A genome-wide search for human type 1 diabetes susceptibility genes. Nature (1994) 7.13

Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet (2005) 6.48

Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet (2007) 6.11

Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94

Next-generation genomics: an integrative approach. Nat Rev Genet (2010) 5.88

Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol (2004) 5.24

Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet (2005) 5.00

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science (2011) 4.96

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes (2004) 4.81

Generalized T2 test for genome association studies. Am J Hum Genet (2002) 4.55

Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet (2004) 4.46

HL-A antigens and diabetes mellitus. Lancet (1974) 4.42

Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 4.36

Genetic analysis of autoimmune disease. Cell (1996) 3.87

The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70

Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet (1997) 3.62

Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol (2007) 3.52

Thyroiditis. N Engl J Med (2003) 3.52

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) (2007) 3.17

A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet (2005) 3.15

CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun (2008) 2.76

Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev (2010) 2.71

Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 2.59

Tag SNP selection for association studies. Genet Epidemiol (2004) 2.52

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab (2004) 2.44

Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol (2010) 2.44

A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology (2005) 2.43

Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood (1999) 2.40

IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PLoS Genet (2009) 2.30

Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes (1973) 2.21

Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab (2001) 2.10

HL-A system and diabetes mellitus. Diabetes (1975) 2.08

Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet (2005) 1.72

Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab (1998) 1.72

A population-based study of Graves' disease in Danish twins. Clin Endocrinol (Oxf) (1998) 1.67

A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun (2007) 1.66

Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A (1995) 1.66

Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid (2007) 1.64

Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet (2003) 1.59

Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57

Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A (1991) 1.54

Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun (2004) 1.52

Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab (2007) 1.49

Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet (2005) 1.49

CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1995) 1.49

Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab (2005) 1.48

Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet (2004) 1.47

Analysis of immune regulatory genes' copy number variants in Graves' disease. Thyroid (2010) 1.47

A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid (2002) 1.41

A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet (2007) 1.35

HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33

Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health (2000) 1.33

Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet (2001) 1.28

Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab (2005) 1.27

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Genet (2009) 1.26

Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by micro-ELISA and immunoblotting. J Clin Endocrinol Metab (1986) 1.26

The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun (2007) 1.25

Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J Exp Med (2004) 1.23

Cloning, sequencing and expression of human TSH receptor. Biochem Biophys Res Commun (1990) 1.23

Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab (1999) 1.20

The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus. Hum Mol Genet (1999) 1.19

CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen. J Immunol (2002) 1.19

IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol (2007) 1.18

Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab (2002) 1.17

HLA , CTLA-4 and PTPN22 : the shared genetic master-key to autoimmunity? Expert Rev Mol Med (2005) 1.16

Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab (2007) 1.14

Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab (2007) 1.13

Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab (1992) 1.08

Association of PTPN22 haplotypes with Graves' disease. J Clin Endocrinol Metab (2006) 1.05

Role of the CD40 locus in Graves' disease. Thyroid (2004) 1.04

The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab (1999) 1.01

Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab (1993) 1.01

Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet (2004) 1.00

CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens (1998) 0.98

A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab (2005) 0.98

Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin Endocrinol (Oxf) (2007) 0.98

Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) (1980) 0.98

Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab (1995) 0.97

Articles by these authors

Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet (2007) 19.04

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature (2003) 13.00

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature (2010) 12.27

FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93

Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes (2004) 4.81

Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet (2012) 3.31

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) (2007) 3.17

Parameters for reliable results in genetic association studies in common disease. Nat Genet (2002) 2.00

The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes. Diabetes Care (2013) 1.88

Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature (2013) 1.79

A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clin Endocrinol (Oxf) (2004) 1.64

Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet (2012) 1.57

Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet (2004) 1.47

A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet (2007) 1.35

Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry. Nat Genet (2011) 1.30

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Genet (2009) 1.26

Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA (2010) 1.07

Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid (2002) 0.98

Donor ABCB1 variant associates with increased risk for kidney allograft failure. J Am Soc Nephrol (2012) 0.98

Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials. Drugs Aging (2013) 0.92

Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS One (2010) 0.90

The search for the genetic contribution to autoimmune thyroid disease: the never ending story? Brief Funct Genomics (2011) 0.89

Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease. Thyroid (2010) 0.86

Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis. J Clin Endocrinol Metab (2013) 0.86

Genetic developments in autoimmune thyroid disease: an evolutionary process. Clin Endocrinol (Oxf) (2007) 0.86

Inhibition of islet immunoreactivity by adiponectin is attenuated in human type 1 diabetes. J Clin Endocrinol Metab (2013) 0.85

Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study. Eur J Hum Genet (2010) 0.83

Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Clin Endocrinol (Oxf) (2010) 0.83

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial. BMJ Open (2013) 0.83

Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression. Clin Endocrinol (Oxf) (2010) 0.80

A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al. Arthritis Rheum (2002) 0.80

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe. J Clin Endocrinol Metab (2014) 0.79

CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology (Oxford) (2009) 0.79

Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes (2013) 0.78

Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months. Diabetes Technol Ther (2009) 0.78

Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK. Autoimmunity (2004) 0.78

Early change in blood glucose concentration is an indicator of mortality in critically ill children. Intensive Care Med (2012) 0.77

The genetics of autoimmune endocrine disease. Clin Endocrinol (Oxf) (2003) 0.77

Copy number variation in common disease. Thyroid (2011) 0.76

Skewing of female X-chromosome inactivation: an epigenetic risk factor for kidney transplantation outcome. Transplantation (2013) 0.75

Early postoperative continuous glucose monitoring in pancreas transplant recipients. Transpl Int (2015) 0.75

The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune disease. Eur J Hum Genet (2003) 0.75

Postoperative impaired glucose tolerance is an early predictor of pancreas graft failure. Diabetologia (2014) 0.75